Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:24 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Cerebra Integrated Technologies Ltd operates in the IT Networking Equipment sector, currently priced at ₹8.50, with a market capitalization of ₹103 crore. The company has experienced significant fluctuations in its revenue, with reported sales of ₹30 crore in June 2022, declining to ₹7 crore by June 2023. This downward trend continued, as sales stood at ₹36 crore for the fiscal year ending March 2025, indicating a stark decrease from ₹231 crore in March 2022. The trailing twelve months (TTM) sales amounted to ₹27 crore, reflecting ongoing challenges in generating consistent revenue. The company’s operating profit margin (OPM) has deteriorated drastically, recording a staggering -239% in June 2025, showcasing severe operational inefficiencies. The decline in revenue can be attributed to increasing competition and potential market saturation within the IT networking space. Furthermore, the company’s fluctuating quarterly sales figures, such as a low of ₹2 crore in June 2025, raise concerns regarding its market positioning and product demand.
Profitability and Efficiency Metrics
Cerebra Integrated Technologies has faced notable challenges in profitability, with a reported net profit of -₹51 crore, indicating a significant loss compared to previous years. The operating profit has also shown a troubling trend, moving from ₹5 crore in June 2022 to a loss of ₹20 crore by December 2023. The low returns on equity (ROE) and capital employed (ROCE), reported at 16.9% and 15.4% respectively, highlight inefficiencies in capital utilization. The interest coverage ratio (ICR) stands at -5.46x, which indicates that the company is unable to cover its interest obligations from its operational income. Furthermore, the cash conversion cycle (CCC) is alarmingly high at 749 days, reflecting inefficiencies in working capital management. These metrics illustrate a company struggling to maintain profitability and operational efficiency, which is critical for investor confidence and long-term sustainability in the competitive IT sector.
Balance Sheet Strength and Financial Ratios
The balance sheet of Cerebra Integrated Technologies reveals a precarious financial position, with total borrowings reported at ₹40 crore against reserves of ₹53 crore. The company’s debt-to-equity ratio stands at 0.24, suggesting a moderate level of leverage, but the high interest coverage ratio further complicates its financial stability. The price-to-book value (P/BV) ratio is notably low at 0.27x, indicating that the market valuation of the company is significantly below its book value, which could reflect investor skepticism regarding its future prospects. The total assets decreased to ₹258 crore by March 2025, down from ₹425 crore in March 2022, raising concerns about asset management and liquidity. Additionally, the current ratio of 1.32 suggests that the company can meet its short-term liabilities, yet the weak operating margins highlight ongoing operational difficulties. Overall, Cerebra’s financial ratios point to a need for strategic restructuring to improve its balance sheet and restore investor confidence.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cerebra Integrated Technologies indicates a significant concentration of ownership among public shareholders, who account for 99.10% of the total shares. Promoter holding remains low at 0.84%, raising concerns about alignment with shareholder interests and potential management effectiveness. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold negligible stakes of 0.00% and 0.01% respectively, reflecting a lack of institutional confidence in the company. The total number of shareholders has decreased from 40,743 in March 2023 to 36,563 by June 2025, indicating a potential exodus of retail investors. Such trends may suggest that the company’s poor financial performance and lack of growth prospects are driving away investors. This lack of institutional backing can further complicate capital raising efforts, which is critical for funding operational improvements and strategic initiatives.
Outlook, Risks, and Final Insight
The outlook for Cerebra Integrated Technologies is fraught with challenges, particularly given its declining revenue and profitability metrics. The company’s significant operational losses and inefficiencies in cash flow management pose considerable risks to its sustainability. Additionally, the high CCC indicates potential liquidity issues that could hinder day-to-day operations. However, if the company can implement effective cost control measures and improve its product offerings, there may be opportunities for recovery. Strengthening investor relations and enhancing communication with shareholders could also foster greater confidence in the management’s ability to navigate these challenges. Nevertheless, the risks associated with market competition and operational inefficiencies remain significant. The future for Cerebra hinges on its ability to reverse current trends and regain traction within the IT networking equipment sector, making strategic pivots and operational improvements paramount for its survival and growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Cerebra Integrated Technologies Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Computer Point Ltd | 14.4 Cr. | 4.81 | 8.88/4.24 | 11.1 | 0.00 % | 0.06 % | 0.36 % | 10.0 | |
| Brisk Technovision Ltd | 20.0 Cr. | 100 | 208/94.5 | 20.6 | 35.4 | 3.00 % | 18.8 % | 14.0 % | 10.0 |
| Benchmark Computer Solutions Ltd | 21.3 Cr. | 31.0 | 60.0/23.6 | 12.6 | 39.4 | 0.00 % | 8.11 % | 6.44 % | 10.0 |
| ACI Infocom Ltd | 17.2 Cr. | 1.56 | 3.67/1.50 | 1.48 | 0.00 % | 5.89 % | 5.83 % | 1.00 | |
| TVS Electronics Ltd | 1,129 Cr. | 606 | 741/271 | 49.8 | 0.00 % | 1.88 % | 5.61 % | 10.0 | |
| Industry Average | 1,323.56 Cr | 407.45 | 49.70 | 105.43 | 0.63% | 14.23% | 11.91% | 7.00 |
All Competitor Stocks of Cerebra Integrated Technologies Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 29 | 13 | 13 | 7 | 18 | 12 | 15 | 10 | 12 | 11 | 3 | 2 |
| Expenses | 25 | 25 | 11 | 15 | 13 | 31 | 32 | 18 | 19 | 21 | 25 | 4 | 6 |
| Operating Profit | 5 | 4 | 2 | -1 | -7 | -13 | -20 | -3 | -9 | -9 | -15 | -1 | -4 |
| OPM % | 17% | 14% | 16% | -11% | -97% | -72% | -167% | -21% | -89% | -76% | -137% | -59% | -239% |
| Other Income | 0 | -0 | 0 | 0 | 0 | 0 | -8 | 1 | 0 | -10 | -2 | -4 | -10 |
| Interest | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 3 | 2 | 0 | -5 | -8 | -15 | -30 | -3 | -11 | -21 | -18 | -7 | -16 |
| Tax % | 22% | 22% | 23% | -63% | 0% | 10% | 0% | -306% | 0% | 0% | -55% | 13% | -9% |
| Net Profit | 2 | 1 | 0 | -2 | -8 | -16 | -30 | 6 | -11 | -21 | -8 | -8 | -14 |
| EPS in Rs | 0.18 | 0.10 | 0.03 | -0.14 | -0.69 | -1.33 | -2.46 | 0.49 | -0.88 | -1.70 | -0.68 | -0.64 | -1.16 |
Last Updated: August 20, 2025, 12:20 pm
Below is a detailed analysis of the quarterly data for Cerebra Integrated Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Expenses, as of Jun 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Jun 2025, the value is -4.00 Cr.. The value appears to be declining and may need further review. It has decreased from -1.00 Cr. (Mar 2025) to -4.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is -239.00%. The value appears to be declining and may need further review. It has decreased from -59.00% (Mar 2025) to -239.00%, marking a decrease of 180.00%.
- For Other Income, as of Jun 2025, the value is -10.00 Cr.. The value appears to be declining and may need further review. It has decreased from -4.00 Cr. (Mar 2025) to -10.00 Cr., marking a decrease of 6.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -16.00 Cr.. The value appears to be declining and may need further review. It has decreased from -7.00 Cr. (Mar 2025) to -16.00 Cr., marking a decrease of 9.00 Cr..
- For Tax %, as of Jun 2025, the value is -9.00%. The value appears to be improving (decreasing) as expected. It has decreased from 13.00% (Mar 2025) to -9.00%, marking a decrease of 22.00%.
- For Net Profit, as of Jun 2025, the value is -14.00 Cr.. The value appears to be declining and may need further review. It has decreased from -8.00 Cr. (Mar 2025) to -14.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.16. The value appears to be declining and may need further review. It has decreased from -0.64 (Mar 2025) to -1.16, marking a decrease of 0.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:33 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 130 | 267 | 238 | 250 | 314 | 385 | 182 | 70 | 231 | 86 | 50 | 36 | 27 |
| Expenses | 128 | 261 | 236 | 237 | 272 | 343 | 149 | 61 | 188 | 76 | 88 | 70 | 57 |
| Operating Profit | 3 | 7 | 2 | 13 | 42 | 42 | 33 | 9 | 42 | 10 | -38 | -35 | -30 |
| OPM % | 2% | 3% | 1% | 5% | 13% | 11% | 18% | 12% | 18% | 11% | -75% | -97% | -109% |
| Other Income | 1 | 0 | 3 | 1 | 2 | -18 | -15 | 0 | 5 | 0 | -12 | -15 | -25 |
| Interest | 1 | 3 | 3 | 1 | 2 | 4 | 3 | 4 | 6 | 10 | 6 | 6 | 6 |
| Depreciation | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 2 | 3 | 2 | 13 | 42 | 20 | 14 | 4 | 40 | 0 | -56 | -57 | -61 |
| Tax % | 12% | 11% | 17% | 7% | 17% | 71% | 15% | 68% | 32% | -1,475% | -13% | -16% | |
| Net Profit | 2 | 2 | 2 | 12 | 35 | 6 | 12 | 1 | 27 | 3 | -48 | -47 | -51 |
| EPS in Rs | 0.30 | 0.22 | 0.17 | 1.04 | 2.69 | 0.36 | 0.94 | 0.14 | 2.26 | 0.21 | -3.99 | -3.90 | -4.18 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 500.00% | 191.67% | -82.86% | 100.00% | -91.67% | 2600.00% | -88.89% | -1700.00% | 2.08% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 500.00% | -308.33% | -274.52% | 182.86% | -191.67% | 2691.67% | -2688.89% | -1611.11% | 1702.08% |
Cerebra Integrated Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -18% |
| 5 Years: | -28% |
| 3 Years: | -46% |
| TTM: | -51% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -25% |
| 3 Years: | -47% |
| 1 Year: | -51% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -2% |
| 3 Years: | -9% |
| Last Year: | -14% |
Last Updated: September 5, 2025, 1:50 am
Balance Sheet
Last Updated: June 16, 2025, 12:18 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 48 | 84 | 96 | 108 | 120 | 121 | 121 | 121 | 112 | 112 | 112 | 112 |
| Reserves | 45 | 49 | 52 | 66 | 136 | 147 | 173 | 171 | 146 | 148 | 100 | 53 |
| Borrowings | 7 | 40 | 19 | 3 | 3 | 4 | 13 | 18 | 32 | 41 | 39 | 40 |
| Other Liabilities | 79 | 59 | 14 | 155 | 104 | 193 | 141 | 73 | 135 | 98 | 101 | 53 |
| Total Liabilities | 178 | 231 | 181 | 332 | 363 | 466 | 448 | 384 | 425 | 399 | 352 | 258 |
| Fixed Assets | 8 | 7 | 6 | 6 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 12 |
| CWIP | 0 | 0 | 0 | 3 | 0 | 0 | 68 | 73 | 3 | 3 | 3 | 0 |
| Investments | 0 | 0 | 1 | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 170 | 224 | 174 | 323 | 340 | 456 | 371 | 301 | 412 | 386 | 340 | 246 |
| Total Assets | 178 | 231 | 181 | 332 | 363 | 466 | 448 | 384 | 425 | 399 | 352 | 258 |
Below is a detailed analysis of the balance sheet data for Cerebra Integrated Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 112.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 112.00 Cr..
- For Reserves, as of Mar 2025, the value is 53.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Mar 2024) to 53.00 Cr., marking a decrease of 47.00 Cr..
- For Borrowings, as of Mar 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 39.00 Cr. (Mar 2024) to 40.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 53.00 Cr.. The value appears to be improving (decreasing). It has decreased from 101.00 Cr. (Mar 2024) to 53.00 Cr., marking a decrease of 48.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 258.00 Cr.. The value appears to be improving (decreasing). It has decreased from 352.00 Cr. (Mar 2024) to 258.00 Cr., marking a decrease of 94.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 246.00 Cr.. The value appears to be declining and may need further review. It has decreased from 340.00 Cr. (Mar 2024) to 246.00 Cr., marking a decrease of 94.00 Cr..
- For Total Assets, as of Mar 2025, the value is 258.00 Cr.. The value appears to be declining and may need further review. It has decreased from 352.00 Cr. (Mar 2024) to 258.00 Cr., marking a decrease of 94.00 Cr..
Notably, the Reserves (53.00 Cr.) exceed the Borrowings (40.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -4.00 | -33.00 | -17.00 | 10.00 | 39.00 | 38.00 | 20.00 | -9.00 | 10.00 | -31.00 | -77.00 | -75.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 310 | 134 | 96 | 315 | 233 | 321 | 499 | 889 | 299 | 596 | 876 | 759 |
| Inventory Days | 39 | 26 | 4 | 4 | 22 | 5 | 34 | 212 | 48 | 269 | 237 | 129 |
| Days Payable | 208 | 72 | 16 | 247 | 134 | 193 | 302 | 290 | 186 | 310 | 430 | 138 |
| Cash Conversion Cycle | 140 | 87 | 84 | 71 | 121 | 133 | 231 | 811 | 161 | 556 | 683 | 749 |
| Working Capital Days | 139 | 80 | 77 | 93 | 139 | 153 | 265 | 618 | 136 | 370 | 372 | 306 |
| ROCE % | 4% | 3% | 8% | 20% | 17% | 12% | 3% | 15% | 3% | -13% | -15% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -4.22 | -4.32 | 2.45 | 2.45 | 0.10 |
| Diluted EPS (Rs.) | -4.22 | -4.32 | 2.31 | 2.31 | 0.10 |
| Cash EPS (Rs.) | -4.18 | -4.28 | 0.26 | 2.49 | 0.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.72 | 18.75 | 23.06 | 22.84 | 24.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.72 | 18.75 | 23.06 | 22.84 | 24.62 |
| Revenue From Operations / Share (Rs.) | 3.18 | 4.64 | 7.70 | 20.63 | 5.77 |
| PBDIT / Share (Rs.) | -3.07 | -3.23 | 0.91 | 4.21 | 0.72 |
| PBIT / Share (Rs.) | -3.11 | -3.27 | 0.88 | 4.17 | 0.68 |
| PBT / Share (Rs.) | -5.05 | -4.97 | 0.01 | 3.61 | 0.32 |
| Net Profit / Share (Rs.) | -4.22 | -4.32 | 0.22 | 2.45 | 0.10 |
| NP After MI And SOA / Share (Rs.) | -4.22 | -4.32 | 0.22 | 2.45 | 0.13 |
| PBDIT Margin (%) | -96.50 | -69.68 | 11.94 | 20.40 | 12.54 |
| PBIT Margin (%) | -97.75 | -70.50 | 11.45 | 20.21 | 11.92 |
| PBT Margin (%) | -158.75 | -106.98 | 0.17 | 17.51 | 5.59 |
| Net Profit Margin (%) | -132.71 | -92.97 | 2.91 | 11.86 | 1.76 |
| NP After MI And SOA Margin (%) | -132.71 | -92.96 | 2.92 | 11.86 | 2.42 |
| Return on Networth / Equity (%) | -28.67 | -22.78 | 0.96 | 10.63 | 0.57 |
| Return on Capital Employeed (%) | -21.38 | -17.44 | 3.81 | 18.22 | 2.78 |
| Return On Assets (%) | -18.29 | -13.71 | 0.63 | 6.45 | 0.44 |
| Total Debt / Equity (X) | 0.24 | 0.18 | 0.15 | 0.12 | 0.05 |
| Asset Turnover Ratio (%) | 0.11 | 0.13 | 0.20 | 0.56 | 0.17 |
| Current Ratio (X) | 1.32 | 1.37 | 1.64 | 1.52 | 2.51 |
| Quick Ratio (X) | 1.21 | 1.15 | 1.31 | 1.39 | 2.20 |
| Inventory Turnover Ratio (X) | 1.40 | 1.24 | 1.80 | 7.05 | 0.65 |
| Interest Coverage Ratio (X) | -5.46 | -6.07 | 1.08 | 7.54 | 1.98 |
| Interest Coverage Ratio (Post Tax) (X) | -4.06 | -4.92 | 1.28 | 5.39 | 1.28 |
| Enterprise Value (Cr.) | 86.09 | 107.12 | 117.47 | 911.09 | 640.14 |
| EV / Net Operating Revenue (X) | 2.31 | 2.06 | 1.36 | 3.94 | 9.15 |
| EV / EBITDA (X) | -2.40 | -2.96 | 11.41 | 19.32 | 72.97 |
| MarketCap / Net Operating Revenue (X) | 1.26 | 1.37 | 0.93 | 3.82 | 8.92 |
| Price / BV (X) | 0.27 | 0.33 | 0.31 | 3.42 | 2.13 |
| Price / Net Operating Revenue (X) | 1.26 | 1.37 | 0.93 | 3.82 | 8.93 |
| EarningsYield | -1.05 | -0.67 | 0.03 | 0.03 | 0.00 |
After reviewing the key financial ratios for Cerebra Integrated Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -4.22. This value is below the healthy minimum of 5. It has increased from -4.32 (Mar 24) to -4.22, marking an increase of 0.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is -4.22. This value is below the healthy minimum of 5. It has increased from -4.32 (Mar 24) to -4.22, marking an increase of 0.10.
- For Cash EPS (Rs.), as of Mar 25, the value is -4.18. This value is below the healthy minimum of 3. It has increased from -4.28 (Mar 24) to -4.18, marking an increase of 0.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.72. It has decreased from 18.75 (Mar 24) to 14.72, marking a decrease of 4.03.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.72. It has decreased from 18.75 (Mar 24) to 14.72, marking a decrease of 4.03.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3.18. It has decreased from 4.64 (Mar 24) to 3.18, marking a decrease of 1.46.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -3.07. This value is below the healthy minimum of 2. It has increased from -3.23 (Mar 24) to -3.07, marking an increase of 0.16.
- For PBIT / Share (Rs.), as of Mar 25, the value is -3.11. This value is below the healthy minimum of 0. It has increased from -3.27 (Mar 24) to -3.11, marking an increase of 0.16.
- For PBT / Share (Rs.), as of Mar 25, the value is -5.05. This value is below the healthy minimum of 0. It has decreased from -4.97 (Mar 24) to -5.05, marking a decrease of 0.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -4.22. This value is below the healthy minimum of 2. It has increased from -4.32 (Mar 24) to -4.22, marking an increase of 0.10.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.22. This value is below the healthy minimum of 2. It has increased from -4.32 (Mar 24) to -4.22, marking an increase of 0.10.
- For PBDIT Margin (%), as of Mar 25, the value is -96.50. This value is below the healthy minimum of 10. It has decreased from -69.68 (Mar 24) to -96.50, marking a decrease of 26.82.
- For PBIT Margin (%), as of Mar 25, the value is -97.75. This value is below the healthy minimum of 10. It has decreased from -70.50 (Mar 24) to -97.75, marking a decrease of 27.25.
- For PBT Margin (%), as of Mar 25, the value is -158.75. This value is below the healthy minimum of 10. It has decreased from -106.98 (Mar 24) to -158.75, marking a decrease of 51.77.
- For Net Profit Margin (%), as of Mar 25, the value is -132.71. This value is below the healthy minimum of 5. It has decreased from -92.97 (Mar 24) to -132.71, marking a decrease of 39.74.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -132.71. This value is below the healthy minimum of 8. It has decreased from -92.96 (Mar 24) to -132.71, marking a decrease of 39.75.
- For Return on Networth / Equity (%), as of Mar 25, the value is -28.67. This value is below the healthy minimum of 15. It has decreased from -22.78 (Mar 24) to -28.67, marking a decrease of 5.89.
- For Return on Capital Employeed (%), as of Mar 25, the value is -21.38. This value is below the healthy minimum of 10. It has decreased from -17.44 (Mar 24) to -21.38, marking a decrease of 3.94.
- For Return On Assets (%), as of Mar 25, the value is -18.29. This value is below the healthy minimum of 5. It has decreased from -13.71 (Mar 24) to -18.29, marking a decrease of 4.58.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.24. This value is within the healthy range. It has increased from 0.18 (Mar 24) to 0.24, marking an increase of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.11. It has decreased from 0.13 (Mar 24) to 0.11, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has decreased from 1.37 (Mar 24) to 1.32, marking a decrease of 0.05.
- For Quick Ratio (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 4. It has increased from 1.24 (Mar 24) to 1.40, marking an increase of 0.16.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -5.46. This value is below the healthy minimum of 3. It has increased from -6.07 (Mar 24) to -5.46, marking an increase of 0.61.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -4.06. This value is below the healthy minimum of 3. It has increased from -4.92 (Mar 24) to -4.06, marking an increase of 0.86.
- For Enterprise Value (Cr.), as of Mar 25, the value is 86.09. It has decreased from 107.12 (Mar 24) to 86.09, marking a decrease of 21.03.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 2.06 (Mar 24) to 2.31, marking an increase of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is -2.40. This value is below the healthy minimum of 5. It has increased from -2.96 (Mar 24) to -2.40, marking an increase of 0.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.37 (Mar 24) to 1.26, marking a decrease of 0.11.
- For Price / BV (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.33 (Mar 24) to 0.27, marking a decrease of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.37 (Mar 24) to 1.26, marking a decrease of 0.11.
- For EarningsYield, as of Mar 25, the value is -1.05. This value is below the healthy minimum of 5. It has decreased from -0.67 (Mar 24) to -1.05, marking a decrease of 0.38.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cerebra Integrated Technologies Ltd:
- Net Profit Margin: -132.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -21.38% (Industry Average ROCE: 14.23%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -28.67% (Industry Average ROE: 11.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -4.06
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.21
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 49.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.24
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -132.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Networking Equipment | #S-5, Off 3rd Cross, 1 Stage, Pennya Industrial Area, Bengaluru Karnataka 560058 | investors@cerebracomputers.com http://www.cerebracomputers.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. V Ranganathan | Managing Director |
| Mr. P Vishwamurthy | WholeTime Director & CFO |
FAQ
What is the intrinsic value of Cerebra Integrated Technologies Ltd?
Cerebra Integrated Technologies Ltd's intrinsic value (as of 04 November 2025) is 28.13 which is 202.15% higher the current market price of 9.31, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 112 Cr. market cap, FY2025-2026 high/low of 11.9/3.99, reserves of ₹53 Cr, and liabilities of 258 Cr.
What is the Market Cap of Cerebra Integrated Technologies Ltd?
The Market Cap of Cerebra Integrated Technologies Ltd is 112 Cr..
What is the current Stock Price of Cerebra Integrated Technologies Ltd as on 04 November 2025?
The current stock price of Cerebra Integrated Technologies Ltd as on 04 November 2025 is 9.31.
What is the High / Low of Cerebra Integrated Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cerebra Integrated Technologies Ltd stocks is 11.9/3.99.
What is the Stock P/E of Cerebra Integrated Technologies Ltd?
The Stock P/E of Cerebra Integrated Technologies Ltd is .
What is the Book Value of Cerebra Integrated Technologies Ltd?
The Book Value of Cerebra Integrated Technologies Ltd is 13.6.
What is the Dividend Yield of Cerebra Integrated Technologies Ltd?
The Dividend Yield of Cerebra Integrated Technologies Ltd is 0.00 %.
What is the ROCE of Cerebra Integrated Technologies Ltd?
The ROCE of Cerebra Integrated Technologies Ltd is 15.4 %.
What is the ROE of Cerebra Integrated Technologies Ltd?
The ROE of Cerebra Integrated Technologies Ltd is 16.9 %.
What is the Face Value of Cerebra Integrated Technologies Ltd?
The Face Value of Cerebra Integrated Technologies Ltd is 10.0.